Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
申请人:AbbVie Global Enterprises Ltd.
公开号:US20220211692A1
公开(公告)日:2022-07-07
The present invention provides for compounds of Formula (I)
wherein R
1
, R
2
, R
3
, m and n have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.